Live: Will United Airlines Crush Q2 Earnings Tonight After the Market Closes?

Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

256 Articles

Chris Lange | Jan 7, 2015 at 2:51 PM EST

Wells Fargo’s Top Biotech Stocks for 2015

ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech…

Lee Jackson | Dec 23, 2014 at 9:50 AM EST

RBC’s 5 Top Biotech Stocks to Buy for 2015

One sector that could be poised to do well could be the biotech arena, and the team at RBC has…

Jon C. Ogg | Dec 1, 2014 at 2:10 PM EST

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.

Jon C. Ogg | Nov 25, 2014 at 10:34 AM EST

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

ThinkstockStocks have enjoyed yet another wonderful year in 2014, and the bull market is now more than five and a…

Lee Jackson | Nov 25, 2014 at 8:40 AM EST

RBC Has Three Top Biotech Picks for Year End and 2015

ThinkstockIf any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the…

Lee Jackson | Nov 8, 2014 at 9:10 AM EST

Market Rally Brings Out Insider Sellers in Full Force

With the U.S. markets hitting all-time highs again, insider sellers are more than happy to step up and unload some…

Jon C. Ogg | Oct 13, 2014 at 8:00 AM EDT

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. on Monday, October 13, 2014.

Jon C. Ogg | Oct 7, 2014 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

These are the top analyst upgrades, downgrades and initiations seen on Tuesday, October 7, 2014.

Lee Jackson | Sep 25, 2014 at 8:35 AM EDT

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams…

Jon C. Ogg | Sep 5, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

These are the top analyst upgrades and downgrades covered by 24/7 Wall St. on Friday, September 5, 2014.

Lee Jackson | Jul 28, 2014 at 8:55 AM EDT

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are…

Lee Jackson | Jul 9, 2014 at 8:40 AM EDT

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…

Jon C. Ogg | Jul 8, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Tuesday, July 8, 2014. They include…

Jon C. Ogg | Jun 25, 2014 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, June 25, 2014. They include Apple, Coach,…

Paul Ausick | Jun 24, 2014 at 1:15 PM EDT

The Real Attraction to Vertex After Cystic Fibrosis Success

Vertex Pharmaceuticals has reported that two Phase 3 studies of its lumacaftor cystic fibrosis drug in combination with its Kalydeco…

1 … 9 10 11 12 13 … 18

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Wells Fargo’s Top Biotech Stocks for 2015

RBC’s 5 Top Biotech Stocks to Buy for 2015

5 Critical Biotech Drug Dates and Events for December

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

RBC Has Three Top Biotech Picks for Year End and 2015

Market Rally Brings Out Insider Sellers in Full Force

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

The Real Attraction to Vertex After Cystic Fibrosis Success

Live: Will United Airlines Crush Q2 Earnings Tonight After the Market Closes?

Live: Can J.B. Hunt Keep the 41% YTD Rally Going With Q2 Earnings Tonight?

Why Retirees Are Quietly Moving From SCHD to These Two International Dividend ETFs Paying More Yield

The Cheapest S&P 500 ETF Was Just Picked for Trump Accounts and $30 Billion Followed

Applied Materials Vs. KLA Corporation: This AI Infrastructure Play Is A Better Buy

The $280,000 401(k) Tax Trap: Why RMDs Cost Retirees Far More Than They Expect

Social Security Retirees Just Got a Big Clue About 2027's COLA

Why Retirees Are Quietly Moving From SCHD to These Two International Dividend ETFs Paying More Yield

The Cheapest S&P 500 ETF Was Just Picked for Trump Accounts and $30 Billion Followed

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Wells Fargo’s Top Biotech Stocks for 2015

RBC’s 5 Top Biotech Stocks to Buy for 2015

5 Critical Biotech Drug Dates and Events for December

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

RBC Has Three Top Biotech Picks for Year End and 2015

Market Rally Brings Out Insider Sellers in Full Force

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

The Real Attraction to Vertex After Cystic Fibrosis Success

Live: Will United Airlines Crush Q2 Earnings Tonight After the Market Closes?

Live: Can J.B. Hunt Keep the 41% YTD Rally Going With Q2 Earnings Tonight?

Why Retirees Are Quietly Moving From SCHD to These Two International Dividend ETFs Paying More Yield

The Cheapest S&P 500 ETF Was Just Picked for Trump Accounts and $30 Billion Followed

Applied Materials Vs. KLA Corporation: This AI Infrastructure Play Is A Better Buy

Featured Reads

The $280,000 401(k) Tax Trap: Why RMDs Cost Retirees Far More Than They Expect

Social Security Retirees Just Got a Big Clue About 2027's COLA